PHREESIA INC

Phreesia insider sale: President Linetsky sells 69 shares at $10.76—routine liquidity amid market volatility, hinting no immediate impact on long‑term value.

Phreesia insiders boost shares at 85% ESPP discount, signaling confidence in a near‑term rebound of its healthcare software platform.

Insider buying by Phreesia’s director signals long‑term confidence in its high‑growth patient‑registration platform—boosting investor buzz and highlighting potential upside.

Phreesia’s insider buying by Pale Fire Capital signals a value‑driven bet amid regulatory shifts, low P/E, and a chance to capitalize on telehealth growth.

Phreesia insider sale: Hoffman Allison C sells 6,176 shares at $11.97, sparking investor curiosity about liquidity, rebalancing, and potential valuation limits amid market volatility.

Phreesia’s share surge, backed by a new credit line and a 0.91 % stake from Pale Fire Capital, signals confidence in its SaaS growth plan and debt‑restructuring strategy.

Phreesia insider sale: Hui Yvonne’s 365‑share sell‑to‑cover amid 4.9% dip shows routine liquidity, not confidence loss, amid heavy R&D and a negative P/E.